Latest filing published 13 Sept 2024 for Syra Health Corp, €11.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -81.7%Entry US$0.42 · Close at T+365 US$0.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Priya Prasad: trading record in brief
This profile gathers the share dealings of Priya Prasad in Syra Health Corp. Between 29 September 2023 and 12 September 2024, the trades on record add up to 15 filings.
In open-market terms, that means 11 purchases worth €12k on one side and 4 sales worth €9,450 on the other. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2024, the count stands at 11 purchases and 4 sales.
A typical purchase (the median) is worth €274. Of 9 purchases, 6 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 9 purchases show a median change of -0.7%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
Most recently, on 13 September 2024, the filings show an open-market purchase worth €11 in Syra Health Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Priya Prasad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10 shares@ US$1.210.1% of flowClass A Common StockSEC:0001493152-24-036127:7Canonical exit: 4 Mar 2024 (T+90)
- 2,400 sharesClass A Common StockSEC:0001493152-24-036127:1Canonical exit: 1 Jan 2024 (T+90)
- 500 shares@ US$7.5016.0% of flowClass A Common StockSEC:0001493152-24-036127:13
- 5,303 shares@ US$0.388.4% of flowClass A Common StockSEC:0001493152-24-036127:14Canonical exit: 11 Dec 2024 (T+90)
- 918 shares@ US$3.1912.8% of flowClass A Common StockSEC:0001493152-24-036127:2
- 1,000 shares@ US$2.6611.6% of flowClass A Common StockSEC:0001493152-24-036127:3Canonical exit: 7 Jan 2024 (T+90)
- 435 shares@ US$1.232.3% of flowClass A Common StockSEC:0001493152-24-036127:4Canonical exit: 29 Feb 2024 (T+90)
- 4,271 shares@ US$1.1420.6% of flowClass A Common StockSEC:0001493152-24-036127:5Canonical exit: 3 Mar 2024 (T+90)
- 735 shares@ US$1.153.6% of flowClass A Common StockSEC:0001493152-24-036127:6
- 2,000 shares@ US$1.3111.1% of flowClass A Common StockSEC:0001493152-24-036127:8
- 50 shares@ US$1.220.3% of flowClass A Common StockSEC:0001493152-24-036127:9Canonical exit: 5 Mar 2024 (T+90)
- 10 shares@ US$1.220.1% of flowClass A Common StockSEC:0001493152-24-036127:10Canonical exit: 6 Mar 2024 (T+90)
- 50 shares@ US$1.230.3% of flowClass A Common StockSEC:0001493152-24-036127:11Canonical exit: 7 Mar 2024 (T+90)
- 1 shares@ US$1.180.0% of flowClass A Common StockSEC:0001493152-24-036127:12Canonical exit: 20 Mar 2024 (T+90)
- 918 shares@ US$3.30100.0% of flowClass A Common StockSEC:0001493152-24-036127:0Canonical exit: 28 Dec 2023 (T+90)
15 of 15 declarations